INTRODUCTION: Dabigatran and rivaroxaban have recently been added to the armamentarium
for thromboprophylaxis in orthopedic surgery. Although this is their first licensed …

Fibrin, the coagulation end product, consolidates the platelet plug at sites of vascular injury
and supports the recruitment of circulating platelets. In addition to integrin αIIbβ3, another as-…

Orthotopic liver transplantation (OLT) remains a potentially hemorrhagic procedure. Rotational
thromboelastometry (ROTEM) is a point‐of‐care device used to monitor coagulation …

Background Calibrated Automated Thrombography (CAT) has been widely used to assess
in vitro thrombin generation as an informative intermediary phenotype of coagulation. …

Background This study aimed to determine the prevalence of genetic and environmental
vascular risk factors in non diabetic patients with premature peripheral arterial disease, either …

Introduction: Cerebral venous thrombosis (CVT) is a rare disease with highly variable
clinical presentation and outcome. Etiological assessment may be negative. The clinical and …

Dabigatran etexilate, rivaroxaban and apixaban (DOACs) are widely used and measurement
of their concentration is desirable in certain clinical situations. Target-specific assays are …

La découverte des mutations V et II Leiden a été l’occasion pour beaucoup de biologistes d’entrer
dans le monde de la biologie moléculaire à partir de 1994. Diagnostic moléculaire le …

Introduction The incidence of deep venous thrombosis (DVT) related to a central venous
catheter varies considerably in ICUs depending on the population included. The aim of this …

Aims Diagnosis of hyperfibrinolysis in orthotopic liver transplantation (OLT) remains challenging.
Euglobulin clot lysis time (ECLT) is not adapted to clinical situations. ROTEM is specific …